Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Saved in:
| Title: | Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma. |
|---|---|
| Authors: | Luo Y; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China., Hong CQ; Department of Oncological Laboratory Research, the Cancer Hospital of Shantou University Medical College, Shantou, China., Huang BL; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China.; Guangdong Esophageal Cancer Institute, Guangzhou, China., Ding TY; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China., Chu LY; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China., Zhang B; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China., Qu QQ; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China., Li XH; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China., Liu CT; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China.; Guangdong Esophageal Cancer Institute, Guangzhou, China., Peng YH; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China.; Guangdong Esophageal Cancer Institute, Guangzhou, China., Guo HP; Department of Head and Neck Surgery, the Cancer Hospital of Shantou University Medical College, Shantou, China., Xu YW; Department of Clinical Laboratory Medicine, the Cancer Hospital of Shantou University Medical College, Shantou, China.; Precision Medicine Research Center, Shantou University Medical College, Shantou, China.; Guangdong Esophageal Cancer Institute, Guangzhou, China. |
| Source: | Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 2153-2166. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print Cited Medium: Internet ISSN: 1365-2060 (Electronic) Linking ISSN: 07853890 NLM ISO Abbreviation: Ann Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
